FindTrial
Sign In

Antibodies, Anti-Idiotypic

5 trials

Sponsors

Center of Molecular Immunology (CIM)

Conditions

Advanced Lung Cancer Non-small Cell Lung CancerAdvanced Lung Cancer Small Cell Lung CancerAdvanced non small cell lung cancerBreast carcinoma in stage IV or progressive metastatic diseaseColon adenocarcinoma phase IV or evolvable metastatic disease

Early Phase 1

Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory
Active, not recruitingRPCEC00000279
Center of Molecular Immunology (CIM)Advanced non small cell lung cancer
Start: 2018-07-09Updated: 2026-03-30

Phase 2

1E10 anti-idiotype vaccine, metastatic colon, phase II.
Active, not recruitingRPCEC00000006
Center of Molecular Immunology (CIM)Colon adenocarcinoma phase IV or evolvable metastatic disease
Start: 2002-07-19Target: 40Updated: 2026-03-30
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II
Active, not recruitingRPCEC00000008
Center of Molecular Immunology (CIM)Breast carcinoma in stage IV or progressive metastatic disease
Start: 2003-09-15Target: 80Updated: 2026-03-30
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients
Active, not recruitingRPCEC00000009
Center of Molecular Immunology (CIM)Advanced Lung Cancer Non-small Cell Lung Cancer
Start: 2006-09-27Target: 176Updated: 2026-03-30
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients
Active, not recruitingRPCEC00000010
Center of Molecular Immunology (CIM)Advanced Lung Cancer Small Cell Lung Cancer
Start: 2005-03-03Target: 88Updated: 2026-03-30